InvestorsHub Logo
icon url

1manband

07/16/13 8:37 PM

#65398 RE: ficose #65397

Let's look at Cohen Research's track record, shall we?

PCF*. A real winner of a gold stock. 11 months ago the stock was trading at $0.009 and Cohen put a price target of $0.07 on it. Where is it now? $0.0002. Down 98% since Cohen's "research report".

BLV*. Cohen also had a $0.07 price target when the stock was at $0.0015. Now the stock is $0.0002. Down 87% since Cohen's "research report".

GYS*. Cohen's price target was $0.04 when the stock was trading at $0.0075. Now the stock is $0.0005. Down 93% since Cohen's "research report".

And that is just a small sampling of the POS parade that is Cohen Research. All down BIG. Yup, Cohen's paid "research reports" are really something to get excited about, huh? But hey, it does provide a small one or two day pop in the stock. Enough to allow insiders and their friends to dump into the volume?

I wonder how many of Cohen's other paid research clients also have issued toxic death spiral convertibles? From what I see, quite a few. Coincidence?
icon url

sanbrunobaby

07/17/13 7:18 AM

#65405 RE: ficose #65397

Actually for anyone who believed there was any chance of this company producing this year , or making a profit this year or next, or proceeding with "manageable dilution",I think the report would be an eye-opener.
It is a surprise how company persists in promoting the concept of a NI43-101 report or even NI43-101 compliant report. They just dont seem to grasp the issues involved.